Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2025-01-01
DOI
https://doi.org/10.1093/ecco-jcc/jjaf005
Citations
10
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
18.17
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies

Ramona Vladea, Remo Panaccione, W. Rachel Duan, Marc Ferrante et al.
10 citations
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
18.17
article

Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies

Ramona Vladea, Remo Panaccione, W. Rachel Duan, Marc Ferrante, Laurent Peyrin‐Biroulet, David T. Rubin, Jasmina Kalabic, Pierre Morisset, Geert D’Haens, Édouard Louis, Marla Dubinsky, Karen B. Chien, Patrick Hecht, Su Chen, Yafei Zhang, Ken Takeuchi, Jean–Frédéric Colombel, Ling Cheng, Stefan Schreiber
article en
10 citations

Abstract

No abstract available for this paper.
Journal of Crohn s and ColitisVol. 19(1)
University of Calgary (CA), Ludwigshafen University of Business and Society (DE), McGill University Health Centre (CA), AbbVie (United States) (US), Christian-Albrechts-Universität zu Kiel (DE), University of Chicago (US), Centre Hospitalier Régional et Universitaire de Nancy (FR), Centre d’Investigation Clinique Innovation Technologique de Nancy (FR), University Hospital Schleswig-Holstein (DE), AbbVie (Germany) (DE), Klinikum Ludwigshafen (DE), Centre Hospitalier Universitaire de Liège (BE), Clinique Hartmann (FR), Amsterdam University Medical Centers (NL), Kashiwa Municipal Hospital (JP), Nutrition-Génétique et Exposition aux Risques Environnementaux (FR), University of Amsterdam (NL), University of Lübeck (DE), Icahn School of Medicine at Mount Sinai (US), KU Leuven (BE)
Good health and well-being
Openalex Percentile: Top 1%
Inflammatory Bowel Disease
18.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.